Release Date: November 26, 2024
Expiration Date: November 26, 2025
Activity Overview
This Burst CME is a text- and audio-based program in which 2 faculty experts present and discuss the latest in the diagnosis and management of Demodex blepharitis. Content will focus on clinical gaps associated with a diagnosis of Demodex blepharitis, other ocular surface disorders that contribute to the differential diagnosis, and the latest evidence-based approaches to effective treatment plans for patients with Demodex blepharitis. This unique format is designed to accommodate the busy clinician and provide a quick, go-to resource on the topic.
Target Audience
This online educational activity is directed toward optometrists, ophthalmologists, and other health care professionals involved in the care of patients with Demodex blepharitis.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Outline the clinical gaps associated with the diagnosis of Demodex blepharitis
- Develop a robust differential diagnosis for patients presenting with ocular surface disorders that includes Demodex blepharitis as appropriate.
- Integrate evidence-based approaches in the development of treatment plans for patients with Demodex blepharitis

Jade Coats, OD, FAAO
Lead Refractive Optometrist
McDonald Eye Associates
Rogers, AR
Disclosures: Speakers’ Bureau: Bausch + Lomb, Dompé, Sun Pharmaceutical Industries, Tarsus Pharmaceuticals. Other: AbbVie, Bausch + Lomb, Dompé, Harrow, KALA BIO, Novaliq, Orasis Pharmaceuticals, Sun Pharmaceutical Industries, Tarsus Pharmaceuticals, Thea Pharma, Trukera Medical, Viatris, ZEISS.

Angela Y. Zhu, MD
Assistant Professor of Clinical Ophthalmology
Pediatric and Adult Cornea, Cataract, and External Diseases
Director of Ophthalmology Medical Student Education
Bascom Palmer Eye Institute
University of Miami Miller School of Medicine
Miami, FL
Disclosures: Consultant: Santen.
Faculty, Staff, and Planners’ Disclosures
The staff of Physicians’ Education Resource, LLC, have no relevant financial relationships with ineligible companies.
PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER or any company that provided commercial support for this activity.

GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here



